Dienogest reduces proliferation, aromatase expression and angiogenesis, and increases apoptosis in human endometriosis

Gynecological Endocrinology

Volumn 30, Issue 9, 2014, Pages 644-648

  Miyashita, Mariko ^a   Koga, Kaori ^a   Takamura, Masashi ^a   Izumi, Gentaro ^a   Nagai, Miwako ^a   Harada, Miyuki ^a   Hirata, Tetsuya ^a   Hirota, Yasushi ^a   Fujii, Tomoyuki ^a   Osuga, Yutaka ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Apoptosis; Aromatase; Dienogest; Endometriosis; Proliferation

Indexed keywords

AROMATASE; DIENOGEST; KI 67 ANTIGEN; VON WILLEBRAND FACTOR; ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS; NANDROLONE;

ANGIOGENESIS; APOPTOSIS; ARTICLE; BLOOD VESSEL; CANCER SURGERY; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENDOMETRIUM TUMOR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LAPAROSCOPIC SURGERY; LAPAROTOMY; NICK END LABELING; OVARIAN ENDOMETRIOMA; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALPINGOOOPHORECTOMY; THERAPY EFFECT; ANALOGS AND DERIVATIVES; CASE CONTROL STUDY; DRUG EFFECTS; ENZYMOLOGY; METABOLISM; NEOVASCULARIZATION, PATHOLOGIC; TUNEL ASSAY;

ANTINEOPLASTIC AGENTS, HORMONAL; APOPTOSIS; AROMATASE; CASE-CONTROL STUDIES; CELL PROLIFERATION; ENDOMETRIOSIS; FEMALE; HUMANS; IN SITU NICK-END LABELING; KI-67 ANTIGEN; NANDROLONE; NEOVASCULARIZATION, PATHOLOGIC; VON WILLEBRAND FACTOR;

EID: 84906249854     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.911279     Document Type: Article

References (23)

1. Giudice LC, Kao LC. Endometriosis. Lancet 2004; 364: 1789-99.
2. Davis L, Kennedy SS, Moore J, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2007; 7: Cd001019.
3. Fischer OM, Kaufmann-Reiche U, Moeller C, Fuhrmann U. Effects of dienogest on surgically induced endometriosis in rats after repeated oral administration. Gynecol Obstet Invest 2011; 72: 145-51.
4. Tamura R, Tsuneki I, Yanase T. Effectiveness of the cyclic administration of dienogest in a case of pathological disappearance of intestinal endometriosis. Int J Womens Health 2013; 5: 421-4.
5. Yamanaka K, Xu B, Suganuma I, et al. Dienogest inhibits aromatase and cyclooxygenase-2 expression and prostaglandin E(2) production in human endometriotic stromal cells in spheroid culture. Fertil Steril 2012; 97: 477-82.
6. Fu L, Osuga Y, Morimoto C, et al. Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells. Fertil Steril 2008; 89: 1344-7.
7. Harada T, Momoeda M, Taketani Y, et al. Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis - a randomized, double-blind, multicenter, controlled trial. Fertil Steril 2009; 91: 675-81.
8. Strowitzki T, Marr J, Gerlinger C, et al. Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial. Hum Reprod 2010; 25: 633-41.
9. Strowitzki T, Faustmann T, Gerlinger C, Seitz C. Dienogest in the treatment of endometriosis-associated pelvic pain: a 12-week, randomized, double-blind, placebo-controlled study. Eur J Obstet Gynecol Reprod Biol 2010; 151: 193-8.
10. Koga K, Osuga Y, Yano T, et al. Characteristic images of deeply infiltrating rectosigmoid endometriosis on transvaginal and transrectal ultrasonography. Hum Reprod 2003; 18: 1328-33.
11. Harada M, Osuga Y, Izumi G, et al. Dienogest, a new conservative strategy for extragenital endometriosis: a pilot study. Gynecol Endocrinol 2011; 27: 717-20.
12. Saito A, Koga K, Osuga Y, et al. Individualized management of umbilical endometriosis: A report of seven cases. J Obstet Gynaecol Res 2014; 40: 40-5.
13. Okada H, Nakajima T, Yoshimura T, et al. The inhibitory effect of dienogest, a synthetic steroid, on the growth of human endometrial stromal cells in vitro. Mol Hum Reprod 2001; 7: 341-7.
14. Shimizu Y, Takeuchi T, Mita S, et al. Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression. Mol Hum Reprod 2009; 15: 693-701.
15. Minami T, Kosugi K, Suganuma I, et al. Antiproliferative and apoptotic effects of norethisterone on endometriotic stromal cells in vitro. Eur J Obstet Gynecol Reprod Biol 2013; 166: 76-80.
16. Gomes MK, Rosa-e-Silva JC, Garcia SB, et al. Effects of the levonorgestrel-releasing intrauterine system on cell proliferation, Fas expression and steroid receptors in endometriosis lesions and normal endometrium. Hum Reprod 2009; 24: 2736-45.
17. Acien P, Velasco I, Gutierrez M, Martinez-Beltran M. Aromatase expression in endometriotic tissues and its relationship to clinical and analytical findings. Fertil Steril 2007; 88: 32-8.
18. Lall Seal S, Kamilya G, et al. Aromatase inhibitors in recurrent ovarian endometriomas: report of five cases with literature review. Fertil Steril 2011; 95: 291.e215-98.
19. Bilotas M, Meresman G, Stella I, et al. Effect of aromatase inhibitors on ectopic endometrial growth and peritoneal environment in a mouse model of endometriosis. Fertil Steril 2010; 93: 2513-18.
20. Nakamura M, Katsuki Y, Shibutani Y, Oikawa T. Dienogest, a synthetic steroid, suppresses both embryonic and tumor-cell-induced angiogenesis. Eur J Pharmacol 1999; 386: 33-40.
21. Katayama H, Katayama T, Uematsu K, et al. Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model. Hum Reprod 2010; 25: 2851-8.
22. Okada H, Okamoto R, Tsuzuki T, et al. Progestins inhibit estradiolinduced vascular endothelial growth factor and stromal cell-derived factor 1 in human endometrial stromal cells. Fertil Steril 2011; 96: 786-91.
23. Machado DE, Abrao MS, Berardo PT, et al. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) are significantly higher in patients with deeply infiltrating endometriosis affecting the rectum. Fertil Steril 2008; 90: 148-55.